3Horita Y, Honmou O, Harada K, et al. Intravenous adminis- tration of glial cell line - derived neurotrophic factor gene - modified human mesenchymal stem cells protects against in- jury in a cerebral ischemia model in the adult rat. J Neurosci Res, 2006, 84(7) :1495 - 1504.
4Shen LH, Li Y, Chen J, et al. Intracarotid transplantation of bone marrow stromal cells increases axon - myel in remod- eling after stroke. Ncuroseienec, 2006,137 ( 2 ) : 393 - 399.
5Grayson WL, Zhao F, Bunnell B, et al. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun, 2007, 358 (3) : 948 - 953.
6Liu H, Honmou O, Harada K, et al. Neuro protection by P1GF gene - modified human mesenehymal stem cells after cerebral isehaemia. Brain, 2006, 129 ( Pt 10) : 2734 - 2745.
7Crigler L, Robey RC, Asawachaieharn A, et al. Human mesenchymal stem cell subpopulations express a variety of neuro- regulatory molecules and promote neuronal cell sur- vival and neuritogenesis. Exp Neurol, 2006, 198 (1) :54 - 64.
8Nandoe Tewarie R, Hurtado A, Levi AD, et al. Bone mar- row stromal cells for repair of the spinal cord: towards clini- cal application. Cell Transplant, 2006, 15 (7) :563 - 577.
9Horita Y, Honmou O, Harada K, et al. Intravenous adminis tration of glial cell line - derived neurotrophic factor gene - modified human mesenchymal stem cells protects against in- jury in a cerebral ischemia model in the adult rat. J Neurosci Res, 2006, 84(7) :1495 - 1504.
10Unger EC. How can superparamagnetic iron oxides be usedto monitor disease and treatment. Radiology, 2003, 229 (3) : 615-616.
2Schtifer R, Bantleon R, Kehlbach R, et al. Functional investigations on human mesenchymal stem cells exposed to magnetic fields and labeled with clinically approved iron nanoparticles [ J]. BMC Cell Biol,2010,11:22.
3Ngnyen HS, Oster M, Uzan S, et al. Maternal neoangiogenesis dur- ing pregnancy partly derives from fetal endothelial progenitor cells [J]. Prec Natl Acad Sci USA,2007,104(6) :1871-1876.
4Cao F, Drukker M, Lin S, et al. Molecular imaging of embryonic stem cell misbehavior and suicide gene ablation [ J ]. Cloning Stem Cells,2007,9( 1 ) :107-117.
5Kadayakkara DK,Janjic JM ,Pusateri LK,et al. In vivo observation of intraeellular oximetry in perfluoroearbon-labeled glioma cells and chemotherapeutic response in the CNS using fluorine-19 MRI[J]. Magn Reson Med,2010,64(5) :1252-1259.
6Himmelreich U, Weber R, Ramos-Cabrer P, et al. Improved stem cell MRI detectability in animal models by modification of the in- halation gasFJ]. Mol Imaging,2005,4(2) :104-109.
7Gilad AA, Van Laarhoven HW, Mcmahon MT, et al. Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles[ J]. Magn Reson Med, 2009,61 (4) :970-974.
8Wang L, Neoh KG, Kang ET, et al. Biodegradable magnetic-tluores- cent magetite/poly( dl-lactic acid-colalpha,beta-malic acid) com- posite nanoparticles for stem cell labeling [ J ]. Biomaterials, 2010, 31 ( 13 ) :3502-3511.
9Lee ES, Shuter B, Chan J, et al. The use of microgel iron oxide nanoparticles in studies of magnetic resonance relaxation and endo- thelial progenitor cell labelling [ J ]. Biomaterials, 2010,31 ( 12 ) : 3296-3306.
10Harush-Frenkel O, Debotton N, Benita S, et al. Targeting of nanop- articles to the clathrin-mediated endocytic pathway [ J ]. Biochem Biophys Res Commun ,2007,353 ( 1 ) :26-32.
